India  /  Published 16.09.20

Vaccine: nod to resume trials

Drugs Controller General of India (DCGI) Dr V G Somani has gave permission to Serum Institute of India to resume clinical trial of the Oxford Covid-19 vaccine candidate in the country while revoking i...
By Our Bureau, Agencies in

India  /  Published 15.09.20

Hunt news, not women, media told

Filmmakers Mira Nair, Farhan Akhtar and Anurag Kashyap and actress Sonam Kapoor are among over 2,500 people who have signed an open letter condemning the media’s “witch-hunt” of Rhea...
By PTI in Mumbai

India  /  Published 15.09.20

Bollywood: Jaya speaks up

By Our Special Correspondent in New Delhi

India  /  Published 09.09.20

Rhea shifted to Byculla jail

A day after the Narcotics Control Bureau (NCB) arrested her, Rhea Chakraborty was on Wednesday shifted from the anti-drug agency's office in south Mumbai to the Byculla jail. Shortly after her ar...
By Our Bureau, Agencies in Mumbai

India  /  Published 08.09.20

Second Kannada actress in drugs net

A second Kannada actress was arrested on Tuesday in connection with a drugs scandal that has straddled the worlds of showbiz and politics. Sanjjanaa Galrani, who has acted across the southern film in...
By K.M. Rakesh in Bangalore

India  /  Published 08.09.20

Rhea arrested by NCB

Rhea Chakraborty has been arrested by the Narcotics Control Bureau (NCB) after three days of questioning in connection with drugs-related allegations in the Sushant Singh Rajput case, newsagencies and...
By Our Bureau and Agencies in Mumbai, New Delhi

India  /  Published 01.09.20

BJP: drug money use slur on party

Former Karnataka chief minister H.D. Kumaraswamy has triggered a war of words by alleging that drug money helped the BJP topple the coalition government he helmed until a year ago. Still smarting fro...
By K.M. Rakesh in Bangalore

Opinion  /  Published 27.07.20

An opaque model of drug approval in India

In a break from regular procedure to approve new drugs, the Drugs Controller General of India recently approved Biocon’s therapeutic candidate, itolizumab, for the treatment of Covid-19 patients...
By Dinesh Thakur in

India  /  Published 27.07.20

Covid: Itolizumab protocol cloud

The National Task Force on the new coronavirus disease has decided that there is not enough evidence yet to include the drug itolizumab in Covid-19 treatment protocols even though India’s drug r...
By G.S. Mudur in New Delhi

India  /  Published 20.07.20

Favipiravir: scan on cost, drug-maker's claims

India’s drug regulatory authority, acting on a complaint from a member of Parliament, has sought clarifications from Mumbai-based Glenmark Pharmaceuticals over the cost of and allegedly false cl...
By G.S. Mudur in New Delhi


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.